Exploring bias in platelet P2Y1 signalling: Host defence versus haemostasis

被引:1
|
作者
Pan, Dingxin [1 ]
Ladds, Graham [2 ]
Rahman, Khondaker Miraz [3 ]
Pitchford, Simon C. [1 ,4 ]
机构
[1] Sackler Inst Pulm Pharmacol, Inst Pharmaceut Sci, Kings Coll London, London, England
[2] Univ Cambridge, Dept Pharmacol, Cambridge, England
[3] Inst Pharmaceut Sci, Kings Coll London, Chem Biol Grp, London, England
[4] Sackler Inst Pulm Pharmacol, Inst Pharmaceut Sci, Kings Coll London, 5-43 Franklin Wilkins Bldg, 150 Stamford St, Water, London SE1 9NH, England
基金
英国医学研究理事会;
关键词
aggregation; biased agonism; chemotaxis; haemostasis; inflammation; P2Y(1); platelets; NEUTROPHIL RECRUITMENT; SHAPE CHANGE; LEUKOCYTE RECRUITMENT; CONCISE GUIDE; MOLECULAR-BASIS; ALPHA-GRANULES; PROTEIN-KINASE; BLEEDING-TIME; ADP RECEPTORS; P-SELECTIN;
D O I
10.1111/bph.16191
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Platelets are necessary for maintaining haemostasis. Separately, platelets are important for the propagation of inflammation during the host immune response against infection. The activation of platelets also causes inappropriate inflammation in various disease pathologies, often in the absence of changes to haemostasis. The separate functions of platelets during inflammation compared with haemostasis are therefore varied and this will be reflected in distinct pathways of activation. The activation of platelets by the nucleotide adenosine diphosphate (ADP) acting on P2Y(1) and P2Y(12) receptors is important for the development of platelet thrombi during haemostasis. However, P2Y(1) stimulation of platelets is also important during the inflammatory response and paradoxically in scenarios where no changes to haemostasis and platelet aggregation occur. In these events, Rho-GTPase signalling, rather than the canonical phospholipase C & beta; (PLC & beta;) signalling pathway, is necessary. We describe our current understanding of these differences, reflecting on recent advances in knowledge of P2Y(1) structure, and the possibility of biased agonism occurring from activation via other endogenous nucleotides compared with ADP. Knowledge arising from these different pathways of P2Y(1) stimulation of platelets during inflammation compared with haemostasis may help therapeutic control of platelet function during inflammation or infection, while preserving essential haemostasis.
引用
收藏
页码:580 / 592
页数:13
相关论文
共 50 条
  • [21] Potentiation of platelet aggregation by heparin in human whole blood is attenuated by P2Y12 and P2Y1 antagonists but not aspirin
    Storey, RF
    May, JA
    Heptinstall, S
    THROMBOSIS RESEARCH, 2005, 115 (04) : 301 - 307
  • [22] Platelet P2Y1 receptor exhibits constitutive G protein signaling and β-arrestin 2 recruitment
    Ribes, Agnes
    Garcia, Cedric
    Gratacap, Marie-Pierre
    Kostenis, Evi
    Martinez, Laurent O.
    Payrastre, Bernard
    Senard, Jean-Michel
    Gales, Celine
    Pons, Veronique
    BMC BIOLOGY, 2023, 21 (01)
  • [23] Synergistic Inhibition of Both P2Y1 and P2Y12 Adenosine Diphosphate Receptors As Novel Approach to Rapidly Attenuate Platelet-Mediated Thrombosis
    Gremmel, Thomas
    Yanachkov, Ivan B.
    Yanachkova, Milka I.
    Wright, George E.
    Wider, Joseph
    Undyala, Vishnu V. R.
    Michelson, Alan D.
    Frelinger, Andrew L., III
    Przyklenk, Karin
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2016, 36 (03) : 501 - 509
  • [24] New highly active antiplatelet agents with dual specificity for platelet P2Y1 and P2Y12 adenosine diphosphate receptors
    Yanachkov, Ivan B.
    Chang, Hung
    Yanachkova, Milka I.
    Dix, Edward J.
    Berny-Lang, Michelle A.
    Gremmel, Thomas
    Michelson, Alan D.
    Wright, George E.
    Frelinger, Andrew L., III
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 107 : 204 - 218
  • [25] Dimorphism in the P2Y1 ADP receptor gene is associated with increased platelet activation response to ADP
    Hetherington, SL
    Singh, RK
    Lodwick, D
    Thompson, JR
    Goodall, AH
    Samani, NJ
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (01) : 252 - 257
  • [26] 2-Aminothiazole based P2Y1 antagonists as novel antiplatelet agents
    Pi, Zulan
    Sutton, James
    Lloyd, John
    Hua, Ji
    Price, Laura
    Wu, Qimin
    Chang, Ming
    Zheng, Joanna
    Rehfuss, Robert
    Huang, Christine S.
    Wexler, Ruth R.
    Lam, Patrick Y. S.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (14) : 4206 - 4209
  • [27] Components of traditional Chinese medicine inhibit platelet aggregation by blocking ADP receptor subtypes P2Y1 and P2Y12
    Xiao-liang WANG
    Yi-ying LI
    Hong-yan YANG
    Shaofeng XU
    Ling WANG
    中国药理学与毒理学杂志, 2015, 29(S1) (S1) : 28 - 29
  • [28] Aspirin-Dependent Effects on Purinergic P2Y1 Receptor Expression
    Massimi, Isabella
    Alemanno, Laura
    Guarino, Maria Luisa
    Guerriero, Raffaella
    Mancone, Massimo
    Ceccacci, Andrea
    Frati, Luigi
    Angiolillo, Dominick J.
    Pulcinelli, Fabio M.
    THROMBOSIS AND HAEMOSTASIS, 2019, 119 (05) : 726 - 734
  • [29] Modified diadenosine tetraphosphates with dual specificity for P2Y1 and P2Y12 are potent antagonists of ADP-induced platelet activation
    Chang, H.
    Yanachkov, I. B.
    Dix, E. J.
    Li, Y. F.
    Barnard, M. R.
    Wright, G. E.
    Michelson, A. D.
    Frelinger, A. L., III
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (12) : 2573 - 2580
  • [30] Study of aggregation of platelets lacking the P2Y1 receptor
    Fabre, JE
    King, BF
    Koller, BH
    DRUG DEVELOPMENT RESEARCH, 2001, 52 (1-2) : 150 - 155